Connect to other sites within the UBM Medica Network
Combined Lenalidomide/Rituximab Active in Recurrent Follicular Lymphoma
Combined treatment with lenalidomide/rituximab resulted in better clinical response in patients with recurrent follicular lymphoma than did lenalidomide alone.
Total Resection Associated With Better Survival in Atypical, Malignant Meningioma
Gross total resection was associated with significantly lower all-cause mortality in patients with atypical and malignant meningioma, according to a new study.
Bevacizumab Fails to Improve Angiosarcoma Outcomes With Paclitaxel
Adding bevacizumab to paclitaxel did not improve outcomes in a phase II trial of patients with angiosarcoma.
13 Must-Read Books for Oncologists and Science Enthusiasts
We present an end-of-summer list of must-reads, covering everything from the history of cancer to environmental destruction to the upcoming sixth extinction.
Monoclonal Antibody Effective in Refractory Myeloma
Daratumumab, a monoclonal antibody that targets CD38, was safe and effective in patients with heavily pretreated and refractory multiple myeloma.
Blood Draw Predicts Breast Cancer Relapse
Tracking tumor DNA in the blood of early breast cancer patients following surgery predicted relapse nearly 8 months earlier than conventional imaging.
Hematuria and Abdominal Pain in a 50-Year-Old Man
A 50-year-old man undergoes CT examination for workup of hematuria and abdominal pain. Noncontrast and postcontrast images from the CT are shown. What is your diagnosis?
Immunotherapy in Lung Cancer
In this interview with Dr. Roy S. Herbst, we discuss the FDA approval of nivolumab for lung cancer as well as other immunotherapies under investigation for the treatment of lung cancer.
Beta-Blockers Linked With Extended Ovarian Cancer Survival
Beta-blockers were associated with increased overall survival in women with epithelial ovarian cancer, according to a retrospective study.
High-Dose Combination Therapy Improves Outcomes in CNS Lymphoma
A complex high-dose combination therapy is tolerable and effective in patients with aggressive B-cell lymphoma that has spread to the central nervous system.
By clicking Accept, you agree to become a member of the UBM Medica Community.